|
|
|
40
|
A6219
|
TRANEXAMIC ACID 500MG TAB (REM/SBI)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
2x10
|
BQ
|
14.76
|
0.74
|
TABLET
|
0
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
A6219
|
TRANEXAMIC ACID 500MG TAB (REM) (BQ)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
2x10
|
BQ
|
11.96
|
0.598
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A621D
|
PAUSE 500MG TAB (EMC/COL) TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
PAUSE
|
30'S
|
BQ
|
14.27
|
0.48
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
A621D
|
PAUSE 500MG TAB (EMC) TRANEXAMIC ACID (BQ)
|
TRANEXAMIC ACID
|
PAUSE
|
30'S
|
BQ
|
17.67
|
0.589
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A622A
|
TRANEXAMIC ACID 100MG/ML INJ (SLS/AHI)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
25X5ML
|
BQ
|
76.74
|
3.07
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2022-06-30
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-29
|
|
|
|
41
|
A622A
|
TRANEXAMIC ACID 100MG/ML INJ (SLS) (BQ)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
25X5ML
|
BQ
|
63.72
|
2.5487
|
VIAL
|
15
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A622B
|
TRANEXAMIC ACID 100MG/ML INJ (MON/PHA)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
5X5ML
|
BQ
|
9.79
|
1.96
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|